Startseite Naturwissenschaften Anti-EGFL7 antibodies inhibit rat prolactinoma MMQ cells proliferation and PRL secretion
Artikel Open Access

Anti-EGFL7 antibodies inhibit rat prolactinoma MMQ cells proliferation and PRL secretion

  • Qian Liu , Taoyang Yuan , Hua Gao , Songbai Gui , Yazhuo Zhang und Chuzhong Li EMAIL logo
Veröffentlicht/Copyright: 9. Juli 2018

Abstract

Prolactinoma is the most frequently diagnosed pituitary tumors. Dopamine agonists (DAs) are recognized as first-line therapy; however, approximately 10% patients will develop resistance to DAs therapy. Consequently, a large number of investigations have been carried out to identify novel therapeutic targets. Recently, studies have suggested that epidermal growth factor-like domain 7 (EGFL7) can promote tumor growth, invasion, and angiogenesis. We previously reported that overexpression of EGFL7 might play a crucial role in hormone-producing pituitary adenomas. In the present study, we now demonstrated a significantly higher protein expression of EGFL7 in prolactinoma compared with the normal pituitary gland. However, inhibition of EGFL7 with anti-EGFL7 antibodies significantly reduced the proliferation and PRL secretion of rat prolactinoma MMQ cells. Notably, in vitro administration of anti-EGFL7 antibodies significantly induced MMQ cells apoptosis in a dose-dependent manner. In conclusion, our finding suggests that EGFL7 is significantly overexpressed in prolactinoma and inhibition of EGFL7 with antibodies promoted MMQ cells apoptosis and inhibited PRL secretion. Thus, EGFL7 may serve as a potential novel therapeutic target for prolactinomas.

1 Introduction

Prolactinoma is most frequently associated with pathological hyperprolactinemia, which accounts for approximately 60% of all pituitary adenomas [1]. Prolactinomas secrete an excess of prolactin (PRL), which results in hypogonadism, galactorrhea, and infertility [2]. Dopamine agonists (DAs) remain the first-line therapies for prolactinomas through suppression of PRL secretion and inhibition of tumor growth [3]. The majority of cases with prolactinomas initially respond efficiently to dopamine agonists therapy; however, approximately 10% of cases with prolactinomas will eventually develop resistance to the dopamine agonist therapy or intolerance to their adverse effects [4]. Therefore, novel and efficacious therapies are desired for these patients.

Epidermal growth factor-like domain 7 (EGFL7), an endothelial cell derived-secreted factor plays an essential role in physiologic angiogenesis [5]. Over-expression of EGFL7 is observed in several human solid tumors, including malignant gliomas, breast cancer and colon cancers [6, 7, 8, 9]. Moreover, EGFL7 levels are significantly associated with pathologic characteristics [10, 11]. Previously, we reported that increased EGFL7 expression is correlated with the clinical progression, poor prognosis, and tumor grade in hormone-producing pituitary adenomas [12, 13]. However, the effect of EGFL7 in prolactinoma remains to be completely elucidated.

Therefore, the present study aimed to investigate the tissue expression of EGFL7 in prolactinoma in comparison with the normal pituitary gland. The study further evaluated the effect of inhibition of EGFL7 on proliferation and PRL secretion in rat prolactinoma MMQ cells. Using, tissue microarray we demonstrated a significant overexpression of EGFL7 in a prolactinoma. Moreover, treatment with anti-EGFL7 antibodies exhibited significant inhibition of proliferation and PRL secretion in rat prolactinoma MMQ cells. Notably, in vitro administration of anti-EGFL7 antibodies induced MMQ cells apoptosis in a dose-dependent manner. Taken together, these findings suggest that EGFL7 might serve as a potential novel biomarker for prolactinoma.

2 Materials and Methods

2.1 Patients and specimens

Tissue samples from 12 patients with prolactinomas were obtained from the biobank of Beijing Neurosurgical Institute. All these patients underwent endoscopic transsphenoidal surgery between December 2012 and January 2014 at Tiantan Hospital, Beijing, China. We also received normal human anterior pituitaries from six organ donors that died of non-neurological and non-endocrine diseases. To exclude the possibility of incidental pathologies, all the normal anterior pituitaries were histologically examined using immunohistochemistry. This study was approved by the Ethics Committee of Beijing Tiantan Hospital, and written informed consent was obtained from each patient.

2.2 Immunohistochemistry

The immunohistochemical (IHC) SABC method was performed as described previously[12]. Prolactinoma and pituitary gland specimens were fixed in 10% formaldehyde and embedded in paraffin, and tissue sections of 4 μm were stained with standard hematoxylin-eosin (H&E) stain for histopathological evaluation. IHC analysis with mouse monoclonal anti-EGFL7 antibody (1:200, 2H2 sc-101349; Santa Cruz Biotechnology, California, USA) was performed on the sections using Leica BOND-III (Leica Biosystems, Wetzlar, Germany) automated, random, and continuous-access slide staining system and heat-induced epitope retrieval at a high pH (3 min). The primary antibodies were visualized by Bond Polymer Refine Detection system (Leica Biosystems). The expression of immunostained slides was examined by Aperio AT2 digital scanner (Leica Biosystems). The negative control sections were treated identically with the omission of the primary antibody. Moreover, endothelial cells were used as the positive control, and all controls provided satisfactory results.

2.3 Cell culture

The rat prolactinoma, MMQ pituitary adenoma cell line was obtained from the American Type Cell Collection. MMQ cells were cultured into an F12K medium (Invitrogen, Carlsbad, CA) supplemented with 2.5% fetal bovine serum, 15% horse serum, 100 units/mL penicillin, and 100 units/mL streptomycin at 37°C in a humidified atmosphere of 5% CO2. The culture medium was replaced every other day.

2.4 Cell proliferation assay

Effect of different concentrations of anti-EGFL7 antibodies (10-100 μg/mL) on the proliferation of MMQ cells was assessed by MTS assay following the manufacturers’ protocols. The normal human IgG was used as a control. Briefly, MMQ cells were seeded into 96-well microplates, and cultured in the medium mentioned above containing an incremental concentration of anti-EGFL7 antibodies (0-100 μg/mL) for 24, 48, and 72 h. Subsequently, 20 μL MTS solution (Promega, Madison, WI, USA) was added to each well with 100 μL culture medium for four h at 37 °C. The absorbance was measured at 490 nm with a multi-detection microplate reader (Tecan Infinite® M200 pro, Tecan Group AG, Männedorf, Schweiz). All experiments were performed in triplicate.

2.5 Apoptosis assay

Apoptosis in MMQ cells was quantitatively determined using Annexin V-fluorescein isothiocyanate (FITC) Apoptosis Detection Kit. Briefly, MMQ cells were treated with increasing concentration of anti-EGFL7 antibodies for 72 hours. After treatment MMQ, cells were harvested, washed with PBS and resuspended in 100 μL of binding buffer. A total of 5 μL of Annexin V-FITC was added to each well and incubated for 10 min at 25°C. 10 μL of PI was added in the cells and incubated for another 15 min in the dark. Next, 400 μL binding buffer was added to each well before analysis. Samples were analyzed by imaging flow cytometry (ImageStream X MarkII, Amnis, USA).

2.6 ELISA assay

The PRL secretions from MMQ cells treated with increasing concentration of anti-EGFL7 antibody (0-100 μg/mL) were measured using a rat PRL RapidBio ELISA kit (West Hills, CA, USA) performed as described previously [14]. The color intensity of the reaction product (proportional to the concentration of PRL) was measured using a multi-detection microplate reader (Tecan Infinite® M200 pro, Tecan Group AG, Männedorf, Schweiz). The concentration of PRL was calculated from the standard curve using a straight-line regression equation from the standard curve with the standard density and the OD value.

2.7 Statistical analysis

All data were expressed as the mean ± standard deviation (SD) of at least three independently performed experiments. All statistical analysis was performed using the SPSS 13.0 for Windows (SPSS Inc., Chicago, IL, USA). The statistical significance of the differences among three groups was analyzed by one-way analysis of variance (ANOVA), followed by a least significant difference post-hoc test to obtain individual P values. The value p <0.05 was considered statistically significant.

3 Results

3.1 Overexpression of EGFL7 in prolactinoma tissues

The tissue expression levels of EGFL7 in prolactinoma in comparison with normal pituitary tissue were determined using tissue microarrays and IHC staining. As shown in Figure 1, EGFL7-positive expression was predominantly detected in the cytoplasm. Noticeably higher expression of EGFL7 was observed in prolactinoma than normal pituitary.

Figure 1 Overexpression of EGFL7 in prolactinoma tissues. Representative EGFL7 staining of TMA showed a significantly higher expression of EGFL7 in the cytoplasm of prolactinoma than in normal pituitary tissue. scale bar=200 μm.
Figure 1

Overexpression of EGFL7 in prolactinoma tissues. Representative EGFL7 staining of TMA showed a significantly higher expression of EGFL7 in the cytoplasm of prolactinoma than in normal pituitary tissue. scale bar=200 μm.

3.2 Anti-EGFL7 antibody inhibited the proliferation of MMQ cells

We previously demonstrated that attenuation of EGFL7 expression inhibits the growth of hormone-producing pituitary adenomas progression and invasion [12, 13]. Therefore, to further evaluate the effects and therapeutic potential of inhibition of EGFL7 in prolactinoma, MTS experiments were performed with a commercially available antibody that specifically binds to the EGFL7 protein. As shown in Figure 2, in rat prolactinoma MMQ cells, treatment with increasing concentrations of the anti-EGFL7 blocking antibody led to significant decreases in cell proliferation compared with normal IgG control in a time-dependent manner.

Figure 2 Anti-EGFL7 antibody inhibited the proliferation of MMQ cells by MTS. *P<0.05, **p<0.01 versus normal human IgG control.
Figure 2

Anti-EGFL7 antibody inhibited the proliferation of MMQ cells by MTS. *P<0.05, **p<0.01 versus normal human IgG control.

3.3 EGFL7-blocking antibody inhibited the PRL secretion from MMQ cells

Furthermore, the levels of secreted PRL in the culture supernatant from MMQ cells were also assayed by ELISA using an antibody against the EGFL7 protein. The most representative results after treatment with EGFL7-blocking antibody for 72 h are shown in Figure 3. Treatment of MMQ cells with 50 and 100 μg/mL anti-EGFL7 antibodies for 72 h significantly reduced the level of secreted PRL as compared with normal human IgG control. The serum PRL levels were reduced to 12.56 ± 2.5, 9.29 ± 1.9, and 8.37 ± 1.3 ng/mL in response to 10, 50, and 100 μg/mL of anti-EGFL7 antibodies, respectively (Figure 3) (p < 0.01).

Figure 3 Downregulation of EGFL7 inhibited the PRL secretion from MMQ cells by ELISA. **p<0.01 versus normal human IgG.
Figure 3

Downregulation of EGFL7 inhibited the PRL secretion from MMQ cells by ELISA. **p<0.01 versus normal human IgG.

3.4 EGFL7-blocking antibody induce the apoptosis in MMQ cells

Apoptosis is determined to be responsive to the anti-cancer activities of EGFL7-blocking antibody. Consequently, using Annexin V-FITC/PI staining assay we further evaluated the effect of anti-EGFL7 treatment on apoptosis of MMQ cells by imaging flow cytometry. As shown in Figure 4A and C, the level of apoptosis of MMQ cells increased to 14.6%, 26%, and 47.5%, respectively, corresponding well with the increasing concentrations of anti-EGFL7 antibody (10, 50, and 100 μg/mL) for 72 h. A significant dose-dependent increase in the percentage of induced apoptotic cells was indicated. Conversely, normal human IgG control failed to increase the apoptotic rate in MMQ cells. Furthermore, evaluation of cell morphology and fluorescent staining confirmed standard features of living (AnnV–PI–), early apoptotic (AnnV+PI–) and late apoptotic (AnnV+PI+) cells (Figure 4B). Expression of apoptotic-related proteins was assessed using Western blot. As shown in Figure5, treatment with EGFL7-blocking antibody for 72 h did not affect the expression of Caspase-8 in MMQ cells; however, the activation of caspase-9 and -3 were noted. These results suggested that the apoptosis induced by EGFL7-blocking antibody was through an intrinsic pathway in MMQ cells.

Figure 4 EGFL7-blocking antibody induced the apoptosis in MMQ cells. (A) Dot plot shows viable, early apoptotic, late apoptotic, and necrotic cell populations (AnnV–/PI–, AnnV+PI–, AnnV–/PI+, and AnnV+PI+, respectively). (B) Representative images of each distinct cellular subset. n=4; scale bars = 10 μm. (C) Percent apoptotic MMQ cells (early apoptotic + late apoptotic) at 72 hours.
Figure 4

EGFL7-blocking antibody induced the apoptosis in MMQ cells. (A) Dot plot shows viable, early apoptotic, late apoptotic, and necrotic cell populations (AnnV–/PI–, AnnV+PI–, AnnV–/PI+, and AnnV+PI+, respectively). (B) Representative images of each distinct cellular subset. n=4; scale bars = 10 μm. (C) Percent apoptotic MMQ cells (early apoptotic + late apoptotic) at 72 hours.

Figure 5 EGFL7-blocking antibody-induced apoptosis was dependent on the activation of caspase-9 and -3. MMQ cells treated with or without EGFL7-blocking antibody for 72 hours at indicated concentrations.
Figure 5

EGFL7-blocking antibody-induced apoptosis was dependent on the activation of caspase-9 and -3. MMQ cells treated with or without EGFL7-blocking antibody for 72 hours at indicated concentrations.

4 Discussion

The vascular endothelial growth factor (VEGF) has been validated as an effective anticancer target which mediates tumor angiogenesis [15]. Particularly, probing different angiogenic factors and improving the currently used anti-angiogenic therapy is a reasonable strategy for tumor therapy. Besides, as a vascular-restricted extracellular matrix protein and due to its association with tumor angiogenesis, EGFL7 has emerged as a potent potential target [16]. Therefore, the present study investigated the tissue expression level of EGFL7 in prolactinoma and normal pituitary gland. As demonstrated by the tissue microarray results, there was a significantly higher expression of EGFL7 in prolactinoma compared with normal pituitary tissue. These finding suggested that EGFL7 may play an oncogenic role in prolactinoma and can serve as a potential therapeutic target.

Several studies have revealed the benefits of blocking EGFL7 in tumor models [12, 17, 18]. Recent studies demonstrated that the combination of an anti-EGFL7 antibody and an anti-VEGF enhanced the anti-angiogenic activities and survival prolongation associated with anti-VEGF monotherapy [17]. In the present study, we evaluated the efficacy of antibodies against EGFL7 treatment in rat prolactinoma MMQ cells. Interestingly, there was a significant reduction in the MMQ cell proliferation by blocking of EGFL7 function with anti-EGFL7 monoclonal antibodies. As increased PRL secretion from anterior pituitary lactotrophs leads to various health-related complications including hypogonadism; importantly, we also observed that antibodies against EGFL7 treatment significantly reduced the PRL levels from MMQ cells. These results are consistent with our previous findings which demonstrated that EGFL7 plays a significant role in the progression of hormone-secreting pituitary adenomas.

As imaging flow cytometry combines the statistical power and fluorescence sensitivity of standard flow cytometry with the spatial resolution and quantitative morphology of digital microscopy [19]. In this study, we used the imaging flow cytometry technique to determine the potential effect of EGFL7-blocking treatment on cell viability. The results showed that after exposure to anti-EGFL7 antibodies, strong Annexin V-FITC and PI staining were identified in the cytoplasm and nucleus of the MMQ cells. This evidence suggested that EGFL7 blocking promoted MMQ cells apoptosis.

The major limitation of the present study was small sample size due to non-availability of prolactinoma tissue samples. Consequently, further research may be needed to validate our findings.

In conclusion, EGFL7 may contribute to the regulation of proliferation and PRL secretion in rat prolactinoma MMQ cells through induction of cell apoptosis. Taken together, our finding suggests that EGFL7 is significantly overexpressed in prolactinoma and inhibition of EGFL7 with antibodies promoted MMQ cells apoptosis and inhibited PRL secretion. Thus, EGFL7 may serve as a potential novel therapeutic target for prolactinomas.

Acknowledgements

This work was supported by grants from the National Natural Science Foundation of China (81502154), Research Special Fund For Public Welfare Industry of Health of China(201402008), National High Technology Research and Development Program of China (863 Program, 2015AA020504)

  1. Conflict of interest: The authors declare that they have no competing interests.

References

[1] Colao A., Savastano S., Medical treatment of prolactinomas. Nature reviews Endocrinology., 2011, 7(5), 267-78.10.1038/nrendo.2011.37Suche in Google Scholar PubMed

[2] Gillam M.P., Molitch M.E., Lombardi G., Colao A., Advances in the treatment of prolactinomas. Endocr Rev., 2006, 27(5), 485-534.10.1210/er.2005-9998Suche in Google Scholar PubMed

[3] Klibanski A., Clinical practice. Prolactinomas. N. Engl. J. Med., 2010, 362(13), 1219-26.10.1056/NEJMcp0912025Suche in Google Scholar PubMed

[4] Oh M.C., Aghi M.K., Dopamine agonist-resistant prolactinomas. Journal of neurosurgery, 2011, 114(5), 1369-79.10.3171/2010.11.JNS101369Suche in Google Scholar PubMed

[5] Parker L.H., Schmidt M., Jin S.W., Gray A.M., Beis D., Pham T., et al., The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation. Nature, 2004, 428(6984), 754-8.10.1038/nature02416Suche in Google Scholar PubMed

[6] Wang F.Y., Kang C.S., Wang-Gou S.Y., Huang C.H., Feng C.Y., Li X.J., EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma. Cancer letters, 2017, 384, 9-18.10.1016/j.canlet.2016.10.009Suche in Google Scholar PubMed

[7] Zhang Y., Yang P., Sun T., Li D., Xu X., Rui Y., et al., miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol., 2013, 15(3), 284-94.10.1038/ncb2690Suche in Google Scholar PubMed PubMed Central

[8] Philippin-Lauridant G., Baranzelli M.C., Samson C., Fournier C., Pinte S., Mattot V., et al., Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer. International journal of oncology, 2013, 42(4), 1367-75.10.3892/ijo.2013.1820Suche in Google Scholar PubMed

[9] Diaz R., Silva J., Garcia J.M., Lorenzo Y., Garcia V., Pena C., et al., Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosomes Cancer, 2008, 47(9), 794-802.10.1002/gcc.20580Suche in Google Scholar PubMed

[10] Oh J., Park S.H., Lee T.S., Oh H.K., Choi J.H., Choi Y.S., High expression of epidermal growth factor-like domain 7 is correlated with poor differentiation and poor prognosis in patients with epithelial ovarian cancer. Journal of gynecologic oncology, 2014, 25(4), 334-41.10.3802/jgo.2014.25.4.334Suche in Google Scholar PubMed PubMed Central

[11] Luo W., Shao C., Li N., Zhang F., Guo S., Duan Z., et al., Expression of epidermal growth factor-like domain 7 correlates with clinicopathological features of osteosarcoma. Am J Transl Res., 2015, 7(7), 1236-45.Suche in Google Scholar

[12] Liu Q., Wang J., Yang H., Gao H., Li C., Lan X., et al., Attenuation of EGFL7 expression inhibits growth hormone-producing pituitary adenomas growth and invasion. Hum Gene Ther, (in press), 10.1089/hum.2017.200.Suche in Google Scholar PubMed

[13] Wang J., Liu Q., Gao H., Wan D., Li C., Li Z., et al., EGFL7 participates in regulating biological behavior of growth hormone-secreting pituitary adenomas via Notch2/DLL3 signaling pathway. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2017, 39(7), 1010428317706203.10.1177/1010428317706203Suche in Google Scholar PubMed

[14] Cao L, Gao H, Li P, Gui S, Zhang Y., The Wnt/beta-catenin signaling pathway is involved in the antitumor effect of fulvestrant on rat prolactinoma MMQ cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2014, 35(6), 5121-7.10.1007/s13277-013-1571-8Suche in Google Scholar PubMed

[15] Giantonio B.J., Targeted therapies: Goldie-Coldman and bevacizumab beyond disease progression. Nat Rev Clin Oncol., 2009, 6(6), 311-2.10.1038/nrclinonc.2009.66Suche in Google Scholar PubMed

[16] Cho C.F., Yu L., Nsiama T.K., Kadam A.N., Raturi A., Shukla S., et al., Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature. Nanoscale, 2017, 9(33), 12096-109.10.1039/C7NR02558KSuche in Google Scholar

[17] Papaioannou D., Shen C., Nicolet D., McNeil B., Bill M., Karunasiri M., et al., Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America, 2017, 114(23), E4641-E7.10.1073/pnas.1703142114Suche in Google Scholar PubMed PubMed Central

[18] Johnson L., Huseni M., Smyczek T., Lima A., Yeung S., Cheng J.H., et al., Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy. J Clin Invest., 2013, 123(9), 3997-4009.10.1172/JCI67892Suche in Google Scholar PubMed PubMed Central

[19] Basiji D.A., Ortyn W.E., Liang L., Venkatachalam V., Morrissey P., Cellular image analysis and imaging by flow cytometry. Clin Lab Med., 2007, 27(3), 653-70, viii.10.1016/j.cll.2007.05.008Suche in Google Scholar PubMed PubMed Central

Received: 2018-03-12
Accepted: 2018-04-25
Published Online: 2018-07-09

© 2018 Qian Liu et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Artikel in diesem Heft

  1. Regular Articles
  2. The effect of CuO modification for a TiO2 nanotube confined CeO2 catalyst on the catalytic combustion of butane
  3. The preparation and antibacterial activity of cellulose/ZnO composite: a review
  4. Linde Type A and nano magnetite/NaA zeolites: cytotoxicity and doxorubicin loading efficiency
  5. Performance and thermal decomposition analysis of foaming agent NPL-10 for use in heavy oil recovery by steam injection
  6. Spectroscopic (FT-IR, FT-Raman, UV, 1H and 13C NMR) insights, electronic profiling and DFT computations on ({(E)-[3-(1H-imidazol-1-yl)-1-phenylpropylidene] amino}oxy)(4-nitrophenyl)methanone, an imidazole-bearing anti-Candida agent
  7. A Simplistic Preliminary Assessment of Ginstling-Brounstein Model for Solid Spherical Particles in the Context of a Diffusion-Controlled Synthesis
  8. M-Polynomials And Topological Indices Of Zigzag And Rhombic Benzenoid Systems
  9. Photochemical Transformation of some 3-benzyloxy-2-(benzo[b]thiophen-2-yl)-4Hchromen-4-ones: A Remote Substituent Effect
  10. Dynamic Changes of Secondary Metabolites and Antioxidant Activity of Ligustrum lucidum During Fruit Growth
  11. Studies on the flammability of polypropylene/ammonium polyphosphate and montmorillonite by using the cone calorimeter test
  12. DSC, FT-IR, NIR, NIR-PCA and NIR-ANOVA for determination of chemical stability of diuretic drugs: impact of excipients
  13. Antioxidant and Hepatoprotective Effects of Methanolic Extracts of Zilla spinosa and Hammada elegans Against Carbon Tetrachlorideinduced Hepatotoxicity in Rats
  14. Prunus cerasifera Ehrh. fabricated ZnO nano falcates and its photocatalytic and dose dependent in vitro bio-activity
  15. Organic biocides hosted in layered double hydroxides: enhancing antimicrobial activity
  16. Experimental study on the regulation of the cholinergic pathway in renal macrophages by microRNA-132 to alleviate inflammatory response
  17. Synthesis, characterization, in-vitro antimicrobial properties, molecular docking and DFT studies of 3-{(E)-[(4,6-dimethylpyrimidin-2-yl)imino]methyl} naphthalen-2-ol and Heteroleptic Mn(II), Co(II), Ni(II) and Zn(II) complexes
  18. M-Polynomials and Topological Indices of Dominating David Derived Networks
  19. Human Health Risk Assessment of Trace Metals in Surface Water Due to Leachate from the Municipal Dumpsite by Pollution Index: A Case Study from Ndawuse River, Abuja, Nigeria
  20. Analysis of Bowel Diseases from Blood Serum by Autofluorescence and Atomic Force Microscopy Techniques
  21. Hydrographic parameters and distribution of dissolved Cu, Ni, Zn and nutrients near Jeddah desalination plant
  22. Relationships between diatoms and environmental variables in industrial water biotopes of Trzuskawica S.A. (Poland)
  23. Optimum Conversion of Major Ginsenoside Rb1 to Minor Ginsenoside Rg3(S) by Pulsed Electric Field-Assisted Acid Hydrolysis Treatment
  24. Antioxidant, Anti-microbial Properties and Chemical Composition of Cumin Essential Oils Extracted by Three Methods
  25. Regulatory mechanism of ulinastatin on autophagy of macrophages and renal tubular epithelial cells
  26. Investigation of the sustained-release mechanism of hydroxypropyl methyl cellulose skeleton type Acipimox tablets
  27. Bio-accumulation of Polycyclic Aromatic Hydrocarbons in the Grey Mangrove (Avicennia marina) along Arabian Gulf, Saudi Coast
  28. Dynamic Change of Secondary Metabolites and spectrum-effect relationship of Malus halliana Koehne flowers during blooming
  29. Lipids constituents from Gardenia aqualla Stapf & Hutch
  30. Effect of using microwaves for catalysts preparation on the catalytic acetalization of glycerol with furfural to obtain fuel additives
  31. Effect of Humic Acid on the Degradation of Methylene Blue by Peroxymonosulfate
  32. Serum containing drugs of Gua Lou Xie Bai decoction (GLXB-D) can inhibit TGF-β1-Induced Epithelial to Mesenchymal Transition (EMT) in A549 Cells
  33. Antiulcer Activity of Different Extracts of Anvillea garcinii and Isolation of Two New Secondary Metabolites
  34. Analysis of Metabolites in Cabernet Sauvignon and Shiraz Dry Red Wines from Shanxi by 1H NMR Spectroscopy Combined with Pattern Recognition Analysis
  35. Can water temperature impact litter decomposition under pollution of copper and zinc mixture
  36. Released from ZrO2/SiO2 coating resveratrol inhibits senescence and oxidative stress of human adipose-derived stem cells (ASC)
  37. Validated thin-layer chromatographic method for alternative and simultaneous determination of two anti-gout agents in their fixed dose combinations
  38. Fast removal of pollutants from vehicle emissions during cold-start stage
  39. Review Article
  40. Catalytic activities of heterogeneous catalysts obtained by copolymerization of metal-containing 2-(acetoacetoxy)ethyl methacrylate
  41. Antibiotic Residue in the Aquatic Environment: Status in Africa
  42. Regular Articles
  43. Mercury fractionation in gypsum using temperature desorption and mass spectrometric detection
  44. Phytosynthetic Ag doped ZnO nanoparticles: Semiconducting green remediators
  45. Epithelial–Mesenchymal Transition Induced by SMAD4 Activation in Invasive Growth Hormone-Secreting Adenomas
  46. Physicochemical properties of stabilized sewage sludge admixtures by modified steel slag
  47. In Vitro Cytotoxic and Antiproliferative Activity of Cydonia oblonga flower petals, leaf and fruit pellet ethanolic extracts. Docking simulation of the active flavonoids on anti-apoptotic protein Bcl-2
  48. Synthesis and Characterization of Pd exchanged MMT Clay for Mizoroki-Heck Reaction
  49. A new selective, and sensitive method for the determination of lixivaptan, a vasopressin 2 (V2)-receptor antagonist, in mouse plasma and its application in a pharmacokinetic study
  50. Anti-EGFL7 antibodies inhibit rat prolactinoma MMQ cells proliferation and PRL secretion
  51. Density functional theory calculations, vibration spectral analysis and molecular docking of the antimicrobial agent 6-(1,3-benzodioxol-5-ylmethyl)-5-ethyl-2-{[2-(morpholin-4-yl)ethyl] sulfanyl}pyrimidin-4(3H)-one
  52. Effect of Nano Zeolite on the Transformation of Cadmium Speciation and Its Uptake by Tobacco in Cadmium-contaminated Soil
  53. Effects and Mechanisms of Jinniu Capsule on Methamphetamine-Induced Conditioned Place Preference in Rats
  54. Calculating the Degree-based Topological Indices of Dendrimers
  55. Efficient optimization and mineralization of UV absorbers: A comparative investigation with Fenton and UV/H2O2
  56. Metabolites of Tryptophane and Phenylalanine as Markers of Small Bowel Ischemia-Reperfusion Injury
  57. Adsorption and determination of polycyclic aromatic hydrocarbons in water through the aggregation of graphene oxide
  58. The role of NR2C2 in the prolactinomas
  59. Chromium removal from industrial wastewater using Phyllostachys pubescens biomass loaded Cu-S nanospheres
  60. Hydrotalcite Anchored Ruthenium Catalyst for CO2 Hydrogenation Reaction
  61. Preparation of Calcium Fluoride using Phosphogypsum by Orthogonal Experiment
  62. The mechanism of antibacterial activity of corylifolinin against three clinical bacteria from Psoralen corylifolia L
  63. 2-formyl-3,6-bis(hydroxymethyl)phenyl benzoate in Electrochemical Dry Cell
  64. Electro-photocatalytic degradation of amoxicillin using calcium titanate
  65. Effect of Malus halliana Koehne Polysaccharides on Functional Constipation
  66. Structural Properties and Nonlinear Optical Responses of Halogenated Compounds: A DFT Investigation on Molecular Modelling
  67. DMFDMA catalyzed synthesis of 2-((Dimethylamino)methylene)-3,4-dihydro-9-arylacridin-1(2H)-ones and their derivatives: in-vitro antifungal, antibacterial and antioxidant evaluations
  68. Production of Methanol as a Fuel Energy from CO2 Present in Polluted Seawater - A Photocatalytic Outlook
  69. Study of different extraction methods on finger print and fatty acid of raw beef fat using fourier transform infrared and gas chromatography-mass spectrometry
  70. Determination of trace fluoroquinolones in water solutions and in medicinal preparations by conventional and synchronous fluorescence spectrometry
  71. Extraction and determination of flavonoids in Carthamus tinctorius
  72. Therapeutic Application of Zinc and Vanadium Complexes against Diabetes Mellitus a Coronary Disease: A review
  73. Study of calcined eggshell as potential catalyst for biodiesel formation using used cooking oil
  74. Manganese oxalates - structure-based Insights
  75. Topological Indices of H-Naphtalenic Nanosheet
  76. Long-Term Dissolution of Glass Fibers in Water Described by Dissolving Cylinder Zero-Order Kinetic Model: Mass Loss and Radius Reduction
  77. Topological study of the para-line graphs of certain pentacene via topological indices
  78. A brief insight into the prediction of water vapor transmissibility in highly impermeable hybrid nanocomposites based on bromobutyl/epichlorohydrin rubber blends
  79. Comparative sulfite assay by voltammetry using Pt electrodes, photometry and titrimetry: Application to cider, vinegar and sugar analysis
  80. MicroRNA delivery mediated by PEGylated polyethylenimine for prostate cancer therapy
  81. Reversible Fluorescent Turn-on Sensors for Fe3+ based on a Receptor Composed of Tri-oxygen Atoms of Amide Groups in Water
  82. Sonocatalytic degradation of methyl orange in aqueous solution using Fe-doped TiO2 nanoparticles under mechanical agitation
  83. Hydrotalcite Anchored Ruthenium Catalyst for CO2 Hydrogenation Reaction
  84. Production and Analysis of Recycled Ammonium Perrhenate from CMSX-4 superalloys
  85. Topical Issue on Agriculture
  86. New phosphorus biofertilizers from renewable raw materials in the aspect of cadmium and lead contents in soil and plants
  87. Survey of content of cadmium, calcium, chromium, copper, iron, lead, magnesium, manganese, mercury, sodium and zinc in chamomile and green tea leaves by electrothermal or flame atomizer atomic absorption spectrometry
  88. Biogas digestate – benefits and risks for soil fertility and crop quality – an evaluation of grain maize response
  89. A numerical analysis of heat transfer in a cross-current heat exchanger with controlled and newly designed air flows
  90. Freshwater green macroalgae as a biosorbent of Cr(III) ions
  91. The main influencing factors of soil mechanical characteristics of the gravity erosion environment in the dry-hot valley of Jinsha river
  92. Free amino acids in Viola tricolor in relation to different habitat conditions
  93. The influence of filler amount on selected properties of new experimental resin dental composite
  94. Effect of poultry wastewater irrigation on nitrogen, phosphorus and carbon contents in farmland soil
  95. Response of spring wheat to NPK and S fertilization. The content and uptake of macronutrients and the value of ionic ratios
  96. The Effect of Macroalgal Extracts and Near Infrared Radiation on Germination of Soybean Seedlings: Preliminary Research Results
  97. Content of Zn, Cd and Pb in purple moor-grass in soils heavily contaminated with heavy metals around a zinc and lead ore tailing landfill
  98. Topical Issue on Research for Natural Bioactive Products
  99. Synthesis of (±)-3,4-dimethoxybenzyl-4-methyloctanoate as a novel internal standard for capsinoid determination by HPLC-ESI-MS/MS(QTOF)
  100. Repellent activity of monoterpenoid esters with neurotransmitter amino acids against yellow fever mosquito, Aedes aegypti
  101. Effect of Flammulina velutipes (golden needle mushroom, eno-kitake) polysaccharides on constipation
  102. Bioassay-directed fractionation of a blood coagulation factor Xa inhibitor, betulinic acid from Lycopus lucidus
  103. Antifungal and repellent activities of the essential oils from three aromatic herbs from western Himalaya
  104. Chemical composition and microbiological evaluation of essential oil from Hyssopus officinalis L. with white and pink flowers
  105. Bioassay-guided isolation and identification of Aedes aegypti larvicidal and biting deterrent compounds from Veratrum lobelianum
  106. α-Terpineol, a natural monoterpene: A review of its biological properties
  107. Utility of essential oils for development of host-based lures for Xyleborus glabratus (Coleoptera: Curculionidae: Scolytinae), vector of laurel wilt
  108. Phenolic composition and antioxidant potential of different organs of Kazakh Crataegus almaatensis Pojark: A comparison with the European Crataegus oxyacantha L. flowers
  109. Isolation of eudesmane type sesquiterpene ketone from Prangos heyniae H.Duman & M.F.Watson essential oil and mosquitocidal activity of the essential oils
  110. Comparative analysis of the polyphenols profiles and the antioxidant and cytotoxicity properties of various blue honeysuckle varieties
  111. Special Issue on ICCESEN 2017
  112. Modelling world energy security data from multinomial distribution by generalized linear model under different cumulative link functions
  113. Pine Cone and Boron Compounds Effect as Reinforcement on Mechanical and Flammability Properties of Polyester Composites
  114. Artificial Neural Network Modelling for Prediction of SNR Effected by Probe Properties on Ultrasonic Inspection of Austenitic Stainless Steel Weldments
  115. Calculation and 3D analyses of ERR in the band crack front contained in a rectangular plate made of multilayered material
  116. Improvement of fuel properties of biodiesel with bioadditive ethyl levulinate
  117. Properties of AlSi9Cu3 metal matrix micro and nano composites produced via stir casting
  118. Investigation of Antibacterial Properties of Ag Doped TiO2 Nanofibers Prepared by Electrospinning Process
  119. Modeling of Total Phenolic contents in Various Tea samples by Experimental Design Methods
  120. Nickel doping effect on the structural and optical properties of indium sulfide thin films by SILAR
  121. The effect mechanism of Ginnalin A as a homeopathic agent on various cancer cell lines
  122. Excitation functions of proton induced reactions of some radioisotopes used in medicine
  123. Oxide ionic conductivity and microstructures of Pr and Sm co-doped CeO2-based systems
  124. Rapid Synthesis of Metallic Reinforced in Situ Intermetallic Composites in Ti-Al-Nb System via Resistive Sintering
  125. Oxidation Behavior of NiCr/YSZ Thermal Barrier Coatings (TBCs)
  126. Clustering Analysis of Normal Strength Concretes Produced with Different Aggregate Types
  127. Magnetic Nano-Sized Solid Acid Catalyst Bearing Sulfonic Acid Groups for Biodiesel Synthesis
  128. The biological activities of Arabis alpina L. subsp. brevifolia (DC.) Cullen against food pathogens
  129. Humidity properties of Schiff base polymers
  130. Free Vibration Analysis of Fiber Metal Laminated Straight Beam
  131. Comparative study of in vitro antioxidant, acetylcholinesterase and butyrylcholinesterase activity of alfalfa (Medicago sativa L.) collected during different growth stages
  132. Isothermal Oxidation Behavior of Gadolinium Zirconate (Gd2Zr2O7) Thermal Barrier Coatings (TBCs) produced by Electron Beam Physical Vapor Deposition (EB-PVD) technique
  133. Optimization of Adsorption Parameters for Ultra-Fine Calcite Using a Box-Behnken Experimental Design
  134. The Microstructural Investigation of Vermiculite-Infiltrated Electron Beam Physical Vapor Deposition Thermal Barrier Coatings
  135. Modelling Porosity Permeability of Ceramic Tiles using Fuzzy Taguchi Method
  136. Experimental and theoretical study of a novel naphthoquinone Schiff base
  137. Physicochemical properties of heat treated sille stone for ceramic industry
  138. Sand Dune Characterization for Preparing Metallurgical Grade Silicon
  139. Catalytic Applications of Large Pore Sulfonic Acid-Functionalized SBA-15 Mesoporous Silica for Esterification
  140. One-photon Absorption Characterizations, Dipole Polarizabilities and Second Hyperpolarizabilities of Chlorophyll a and Crocin
  141. The Optical and Crystallite Characterization of Bilayer TiO2 Films Coated on Different ITO layers
  142. Topical Issue on Bond Activation
  143. Metal-mediated reactions towards the synthesis of a novel deaminolysed bisurea, dicarbamolyamine
  144. The structure of ortho-(trifluoromethyl)phenol in comparison to its homologues – A combined experimental and theoretical study
  145. Heterogeneous catalysis with encapsulated haem and other synthetic porphyrins: Harnessing the power of porphyrins for oxidation reactions
  146. Recent Advances on Mechanistic Studies on C–H Activation Catalyzed by Base Metals
  147. Reactions of the organoplatinum complex [Pt(cod) (neoSi)Cl] (neoSi = trimethylsilylmethyl) with the non-coordinating anions SbF6– and BPh4
  148. Erratum
  149. Investigation on Two Compounds of O, O’-dithiophosphate Derivatives as Corrosion Inhibitors for Q235 Steel in Hydrochloric Acid Solution
Heruntergeladen am 23.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/chem-2018-0064/html?lang=de
Button zum nach oben scrollen